Technology
Mortara Instrument Inc. began its worldwide release of its latest resting electrocardiograph (ECG), the ELI 280. The new system combines advanced ECG processing with an intuitive interface, enabling clinicians optimized efficiency in their acquisition of routine diagnostic ECGs.
February 27, 2013
Technology
With Schiller's medilog electrocardiogram (ECG) Holter recorders and the new Fire of Life software, the heart rate variability (HRV) is analyzed and displayed in a new way to help judge the function of the autonomic nervous system.
February 27, 2013
Technology
Cardea Associates announced the launch of its new electrocardiographic (ECG) device, CardeaScreen. Specifically in-tune with normal conditions for the athletic heart, CardeaScreen is designed for use during pre-participation exams (PPE) for sports participants age 14 and older. This U.S. Food and Drug Administration (FDA)-cleared device helps physicians identify abnormal cardiac conditions that could lead to sudden cardiac arrest — at a much lower cost than other ECG systems currently on the market.
February 27, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
Laboratory Corporation of America Holdings (LabCorp) announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.
February 27, 2013
News
The Society of Cardiovascular Computed Tomography (SCCT) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely. The list includes:
February 27, 2013
Feature
Society of Nuclear Medicine and Molecular Imaging Identifies List of Commonly Used Tests to Question
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) released a list of specific tests that are commonly ordered—but not always necessary — in nuclear medicine and molecular imaging as part of the Choosing Wisely campaign, an initiative of the ABIM Foundation. The list identifies five targeted, evidence-based recommendations that can support conversations between patients and physicians about what care is really necessary and appropriate.
February 26, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
February 26, 2013 — TeraMedica debuted the Evercore Connext Mobile at the 2013 HIMSS conference, bringing groundbreaking, seamless point-of-care data capture and archiving to an iPad or iPhone. At the touch of a button, Evercore Connext Mobile acquires photos, videos, sound files, notes and more with the highest level of security. Data is automatically archived directly to the hospital’s Evercore VNA as an integral part of the patient record for viewing through an electronic medical record (EMR) and the integrated TeraMedica Univision viewer.
February 26, 2013
Technology
The TIMS Medical division of Foresight Imaging released the TIMS version 3.0 platform to provide high resolution digital video formats in fluoroscopy and endoscopy.
February 26, 2013Feature
Medtronic Inc. announced it received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Medtronic Native Outflow Tract Transcatheter Pulmonary Valve (TPV). This approval represents the first-ever FDA approval of an investigational device exemption (IDE) following the new draft FDA guidance for early feasibility studies.
February 26, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
The U.S. Food and Drug Administration (FDA) has approved the 34 and 38 mm lengths of the Medtronic Resolute Integrity drug-eluting stent in diameters of 3, 3.5 and 4 mm with an indication for patients with diabetes.
February 25, 2013
Feature
New research at Saint Louis University shows physicians do not talk to patients about the psychosocial impact and long-term risks of implanting cardioverter defibrillators (ICDs) to treat irregular heart rhythms, leaving them misinformed about how the device may affect quality of life.
February 25, 2013
Feature
Taking a leadership role in addressing inefficient practices and improving care, the American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely.
February 25, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Stephanie Wise, Ombud Inc.
The White House’s recent approval of the Physician Payment Sunshine Act mandates transparency within physician-industry relationships. Data recording begins Aug. 1, 2013, so it is necessary for physicians and administrators to understand the implications of this section of the Affordable Care Act.
February 25, 2013
News
The American Heart Association (AHA) is focusing its advocacy efforts across the Midwest on the use of pulse oximetry screening (pulse ox) to detect congenital heart defects in newborns.
February 25, 2013
Technology
The U.S. Food and Drug Administration (FDA) granted final approval for the Biotronik Lumax 740 DX system. The device is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead with atrial sensing capabilities.
February 25, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now